Replies to post #150608 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

What is precision medicine?
According to the Precision Medicine Initiative, precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a one-size-fits-all approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health and healthcare in coming years.

https://ghr.nlm.nih.gov/primer/precisionmedicine/definition

[Talon38]

Nidan, pretty sage logic from my Navy buddy. Think we will soon see action behind the words and revised guidance from Gottlieb and Woodcock. IMHO the slow hand-off from the lead runner (IND) is because the coach has worked hard to get the precision medicine baton into the the speedster's hand on the curve. Anyone who has run a relay knows that it is won in the passing zone. We should see the success of this in the progress of the short Rett trial and with Anavex's 2-73 being chosen as one of the lead ACTC Alzheimer's drugs.

We are looking for a couple of successful "traps".